REGN vs VMC · P/E 14, rev $14.34B vs P/E 35, rev $7.42B
Regeneron Pharmaceuticals Inc (REGN) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the REGN and VMC stock pages for the full models.
Not investment advice.